Literature DB >> 28190271

Increased CTLA-4+ T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease.

Dino B A Tan1,2, Teck-Hui Teo1, Abdul M Setiawan1, Nathanael E Ong2, Maja Zimmermann2, Patricia Price3, Lea-Ann S Kirkham4,5, Yuben P Moodley1,2,6.   

Abstract

Impaired T helper type 1 (Th1) function is implicated in the susceptibility of patients with chronic obstructive pulmonary disease (COPD) to respiratory infections, which are common causes of acute exacerbations of COPD (AECOPD). To understand the underlying mechanisms, we assessed regulatory T (Treg) cells and the expression of an inhibitory T-cell receptor, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Cryopreserved peripheral blood mononuclear cells (PBMC) from patients with AECOPD (n = 17), patients with stable COPD (sCOPD; n = 24) and age-matched healthy non-smoking controls (n = 26) were cultured for 24 hr with brefeldin-A or monensin to detect intracellular or surface CTLA-4 (respectively) by flow cytometry. T cells in PBMC from AECOPD (n = 9), sCOPD (n = 14) and controls (n = 12) were stimulated with anti-CD3 with and without anti-CTLA-4 blocking antibodies and cytokines were quantified by ELISA. Frequencies of circulating T cells expressing intracellular CTLA-4 were higher in sCOPD (P = 0·01), whereas patients with AECOPD had more T cells expressing surface CTLA-4 than healthy controls (P = 0·03). Increased frequencies of surface CTLA-4+ CD4+ T cells and CTLA-4+ Treg cells paralleled increases in plasma soluble tumour necrosis factor receptor-1 levels (r = 0·32, P = 0·01 and r = 0·29, P = 0·02, respectively) in all subjects. Interferon-γ responses to anti-CD3 stimulation were inversely proportional to frequencies of CD4+ T cells expressing intracellular CTLA-4 (r = -0·43, P = 0·01). Moreover, CTLA-4 blockade increased the induction of interferon-γ, tumour necrosis factor-α and interleukin-6 in PBMC stimulated with anti-CD3. Overall, chronic inflammation may expand sub-populations of T cells expressing CTLA-4 in COPD patients and therefore impair T-cell function. CTLA-4 blockade may restore Th1 function in patients with COPD and so aid the clearance of bacterial pathogens responsible for AECOPD.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; acute exacerbations of chronic obstructive pulmonary disease; chronic obstructive pulmonary disease; cytotoxic T-lymphocyte-associated antigen 4; regulatory T cells

Mesh:

Substances:

Year:  2017        PMID: 28190271      PMCID: PMC5418458          DOI: 10.1111/imm.12725

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  CD4-regulatory cells in COPD patients.

Authors:  Lucy J C Smyth; Cerys Starkey; Jorgen Vestbo; Dave Singh
Journal:  Chest       Date:  2007-05-15       Impact factor: 9.410

Review 2.  Immunologic aspects of chronic obstructive pulmonary disease.

Authors:  Manuel G Cosio; Marina Saetta; Alvar Agusti
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

3.  Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement.

Authors:  P S Linsley; J Bradshaw; J Greene; R Peach; K L Bennett; R S Mittler
Journal:  Immunity       Date:  1996-06       Impact factor: 31.745

Review 4.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 5.  Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.

Authors:  Neil MacIntyre; Yuh Chin Huang
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 6.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

Review 7.  CTLA-4 blockade in tumor models: an overview of preclinical and translational research.

Authors:  Joseph F Grosso; Maria N Jure-Kunkel
Journal:  Cancer Immun       Date:  2013-01-22

Review 8.  Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Edward Teo; Hugh House; Kathleen Lockhart; Sai Navya Purchuri; Jennifer Pushparajah; Allan W Cripps; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2014-09-09

9.  T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.

Authors:  Suresh Gopi Kalathil; Amit Anand Lugade; Vandana Pradhan; Austin Miller; Ganapathi Iyer Parameswaran; Sanjay Sethi; Yasmin Thanavala
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

10.  The soluble form of CTLA-4 from serum of patients with autoimmune diseases regulates T-cell responses.

Authors:  Rita Simone; Giampaola Pesce; Princey Antola; Margarita Rumbullaku; Marcello Bagnasco; Nicola Bizzaro; Daniele Saverino
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

View more
  3 in total

Review 1.  Immunodeficiency in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Sheling Xie; Kaifei Wang; Wei Zhang; Kun Xiao; Peng Yan; Yanqin Li; Wanxue He; Yuhan Zhang; Lixin Xie
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease: miRNA and mRNA Regulation.

Authors:  Hongjun Zhao; Quan-Zhen Li; Lijing Wang; Indu Raman; Mei Yan; Qiong Chen
Journal:  J Inflamm Res       Date:  2022-04-01

Review 3.  Role of Regulatory T Cells in Disturbed Immune Homeostasis in Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Jia Hou; Yongchang Sun
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.